Skip to main content
TipRanks
Go Ultimate75% OFF

Cirtran (CIRX) AI Stock Analysis

2 Followers
CIRX

Cirtran

(Other OTC:CIRX)

Select Model
Rating:38Underperform
Price Target:$0.02â–¼(-4.76% Downside)
Action:reiterated
Date:11/14/26

The overall score is severely depressed by a critically insolvent balance sheet and negative operating cash flow, which overshadow a recent surge in reported net income. Technicals confirm persistent bearish momentum, and the distorted valuation reflects a market pricing in high risk of failure.

Positive Factors
Revenue ReboundThe sharp TTM revenue improvement indicates stronger recent business activity and provides a larger operating base for the company’s manufacturing and fulfillment services. If retained, this growth could improve scale, customer relevance, and the ability to absorb fixed operating costs over the next several quarters.
Negative Factors
Negative Stockholders’ EquityPersistently negative equity signals a highly stressed capital structure and leaves the company with limited financial flexibility. It can constrain access to funding, make leverage measures less informative, and increase solvency and refinancing risk if operating performance weakens or additional capital is required.

Cirtran (CIRX) vs. SPDR S&P 500 ETF (SPY)

-50%0%50%100%150%200%CIRX0.00%SPY+14.55%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$107.86K
Dividend Yield
―
Average Volume (3M)
15.53K
Price to Earnings (P/E)
0.0
Beta (1Y)
-1.91
Revenue Growth
288.55%
EPS Growth
―
Country
US
Employees
4
Sector
Industrials
Sector Strength
63
Industry
Food Distribution

Cirtran Business Overview & Revenue Model

Company Description

CirTran Corporation provides manufacturing, marketing, distribution, and technology services for consumer products, including tobacco products, medical devices, and beverages worldwide. The company manufactures, distributes, and sells condoms, electr...

How the Company Makes Money

CirTran’s revenue model is primarily based on charging customers for outsourced operational services. This typically includes (1) electronics manufacturing services (EMS) fees for contract manufacturing, assembly, testing, and related production acti...

Cirtran Financial Statement Overview

Summary

Financial health is critically weak. While TTM revenue surged to $5.0M and net income turned positive, the company is technically insolvent with -$23.3M in equity and is burning cash from operations (-$0.52M), indicating unsustainable finances.

Income Statement

35Negative

Balance Sheet

1Very Negative

Cash Flow

10Very Negative
Financial statement breakdown
BreakdownTTMMar 2026Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue5.05M3.13M1.30M1.62M1.72M2.92M
Gross Profit2.32M1.54M838.64K1.01M1.02M1.90M
EBITDA534.01K276.37K-1.75M221.70K-562.15K-126.73K
Net Income2.26M-701.63K-2.63M20.29M-1.35M-627.38K
Balance Sheet
Total Assets2.65M2.51M1.53M1.85M2.00M1.46M
Cash, Cash Equivalents and Short-Term Investments130.70K9,58930.38K018.08K5,472
Total Debt157.38K3.43M3.36M3.22M3.16M3.22M
Total Liabilities25.93M27.62M25.94M23.63M44.07M42.03M
Stockholders Equity-23.28M-25.11M-24.41M-21.78M-42.07M-40.56M
Cash Flow
Free Cash Flow-523.26K-1.34M-46.35K-81.02K159.30K340.66K
Operating Cash Flow-523.26K-1.34M-46.35K-72.61K159.30K344.46K
Investing Cash Flow0015.40K-8,4140-3,798
Financing Cash Flow634.69K1.35M30.95K62.94K-146.69K-443.33K

Cirtran Technical Analysis

Technical Analysis SentimentNegative
Last Price0.02

Price Trends

50DMA0.03Negative
100DMA0.03Negative
200DMA0.03Negative

Market Momentum

MACD-0.00Negative
RSI40.68Neutral
STOCH-0.00Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CIRX, the sentiment is Negative. The current price of 0.02 is above the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.03, and below the 200-day MA of 0.03, indicating a bearish trend. The MACD of -0.00 indicates Negative momentum. The RSI at 40.68 is Neutral, neither overbought nor oversold. The STOCH value of -0.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CIRX.

Cirtran Risk Analysis

Cirtran disclosed 16 risk factors in its most recent earnings report. Cirtran reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

Cirtran Peers Comparison

Overall Rating

UnderperformOutperform
Sector (63)

Financial Indicators

CIRX against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
TUSKTUSK69Neutral$156.90M11.755.15%―-46.29%88.49%
RCMTRCMT64Neutral$224.92M13.5936.59%―8.68%39.65%
Sector *63Neutral$10.79B15.437.44%2.01%2.89%-14.66%
CODICODI62Neutral$875.75M-14.55-0.18%―12.88%85.04%
NNBRNNBR60Neutral$284.98M-3.49-27.06%―13.92%29.66%
TRCTRC54Neutral$464.99M60.481.61%―45.37%155.95%
CIRXCIRX38Underperform$107.86K0.05-9.61%―288.55%―

* Industrials Sector Average

Performance Comparison

0%50%100%150%200%CIRXCODINNBRRCMTTRCTUSKDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
CIRX and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
CIRXCirtran Corp0.020.0010.53%
CODICompass Diversified11.645.7697.96%
NNBRNN Inc3.041.63115.60%
RCMTRCM (RCMT)31.5412.2463.42%
TRCTejon Ranch17.201.308.18%
TUSKMammoth Energy Services Inc3.261.4176.22%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 14, 2026